通过非靶向同步前体选择质谱蛋白质组学发现未来发生静脉血栓栓塞症的新型血浆生物标志物
研究基于特罗姆瑟研究人群队列,在静脉血栓栓塞症(VTE)事件发生前采集血浆,对200例个体进行非靶向串联质谱标签-同步前体选择-质谱(TMT-SPS-MS3)蛋白质组学分析,在可进行多变量分析的501种蛋白中鉴定出46种与VTE病例对照状态相关(P<0.05),最强候选标志物为转甲状腺素蛋白、维生素K依赖蛋白Z和蛋白/核酸脱甘氨酸酶DJ-1。
要点
- 在VTE事件发生前采集血浆,采用TMT-SPS-MS3非靶向蛋白质组学分析200例个体的血浆蛋白质组。
- 在501种可进行多变量分析的蛋白中,46种与VTE病例对照状态相关,P值低于0.05显著性阈值。
- 按统计学显著性评估的最强预测候选标志物为转甲状腺素蛋白、维生素K依赖蛋白Z和蛋白/核酸脱甘氨酸酶DJ-1。
核心结论
- 非靶向血浆蛋白质组分析发现了新的VTE预测生物标志物候选物,并确认了既往报道的候选物,为研究有效性提供了概念性支持。
- 将开展更大规模的巢式病例对照研究以验证这些发现。
研究设计与样本
- 病例对照研究,纳入参与特罗姆瑟研究(基于人群的队列)的200例个体,血液样本在VTE事件发生前采集。
- 采用非靶向串联质谱标签-同步前体选择-质谱(TMT-SPS-MS3)蛋白质组学分析每位个体的血浆蛋白质组。
主要发现
- 在足够多样本中检测到、可进行多变量分析的501种蛋白中,46种与VTE病例对照状态相关,P值低于0.05显著性阈值。
- 按统计学显著性评估,最强预测候选标志物为转甲状腺素蛋白、维生素K依赖蛋白Z和蛋白/核酸脱甘氨酸酶DJ-1。
临床怎么用
- 原文未据此给出推荐。
局限性
- 将开展更大规模的巢式病例对照研究以验证这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials Discovery of predictive biomarkers of venous thromboembolism (VTE) may aid risk stratification. A case-control study where plasma was sampled before the occurrence of VTE was established. We generated untargeted plasma proteomic profiles of 200 individuals by use of mass spectrometry. Assessment of the biomarker potential of 501 proteins yielded 46 biomarker candidates. ABSTRACT: Background Prophylactic anticoagulant treatment may substantially reduce the incidence of venous thromboembolism (VTE) but entails considerable risk of severe bleeding. Identification of individuals at high risk of VTE through the use of predictive biomarkers is desirable in order to achieve a favorable benefit-to-harm ratio. Objective We aimed to identify predictive protein biomarker candidates of VTE. Methods We performed a case-control study of 200 individuals that participated in the Tromsø Study, a population-based cohort, where blood samples were collected before the VTE events occurred. Untargeted tandem mass tag-synchronous precursor selection-mass spectrometry (TMT-SPS-MS3)-based proteomic profiling was used to study the plasma proteomes of each individual. Results Of the 501 proteins detected in a sufficient number of samples to allow multivariate analysis, 46 proteins were associated with VTE case-control status with P-values below the 0.05 significance threshold. The strongest predictive biomarker candidates, assessed by statistical significance, were transthyretin, vitamin K-dependent protein Z and protein/nucleic acid deglycase DJ-1. Conclusions Our untargeted approach of plasma proteome profiling revealed novel predictive biomarker candidates of VTE and confirmed previously reported candidates, thereby providing conceptual support for the validity of the study. A larger nested case-control study will be conducted to validate our findings.
引用
- Jensen SB, Hindberg K, Solomon T, et al. Discovery of novel plasma biomarkers for future incident venous thromboembolism by untargeted synchronous precursor selection mass spectrometry proteomics. J Thromb Haemost. 2018. PMID: 29964323. doi:10.1111/jth.14220
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。